All In Biotech

NDA 022305 · Niagara Pharms

Pur-Wash

Purified Water · Ophthalmic

Last checked: Nov 20, 2026Latest source record: Feb 2, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2011

Sep 1, 2011

Approved uses

1

Original approval plus efficacy supplements

Registered trials

134

27 Phase 3, 16 recruiting

FAERS reports

679

461 serious, 66 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Dec 9, 2025.

Use For cleansing the eye to help relieve irritation or burning by removing loose foreign material

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

1 products under this application
  • PUR-WASH · PURIFIED WATER 98.3% · SOLUTION, OPHTHALMIC · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Purified Water" as an intervention, any sponsor and status, largest first.

All 134 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • fatigue44
  • pain38
  • nausea36
  • dyspnoea34
  • off label use32
  • drug ineffective30
  • vomiting30
  • headache28
  • malaise28
  • diarrhoea27
  • pyrexia27
  • death24

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20044
20054
20062
20076
20087
20098
201011
201110
201215
20137
201432
201540
201623
201722
201828
201926
202017
202146
202280
202375
202456
202574
202686

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 39 on PubMed

Sponsor: Niagara Pharms

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.